The University of Chicago Header Logo

Connection

Tamar Polonsky to Aged

Back to Details
This is a "connection" page, showing publications Tamar Polonsky has written about Aged.
Tamar Polonsky
Connection Strength
1.046
Aged
  1. Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 Apr; 79(4):893-903.
    View in: PubMed
    Score: 0.063
  2. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.
    View in: PubMed
    Score: 0.053
  3. Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease. J Am Heart Assoc. 2019 07 02; 8(13):e010890.
    View in: PubMed
    Score: 0.046
  4. Durability of Benefits From Supervised Treadmill Exercise in People With Peripheral Artery Disease. J Am Heart Assoc. 2019 01 08; 8(1):e009380.
    View in: PubMed
    Score: 0.045
  5. Ambulatory Blood Pressure Monitoring. JAMA. 2018 Nov 06; 320(17):1807-1808.
    View in: PubMed
    Score: 0.044
  6. Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York. JAMA Cardiol. 2017 06 01; 2(6):627-634.
    View in: PubMed
    Score: 0.040
  7. Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Mar 20; 6(3).
    View in: PubMed
    Score: 0.040
  8. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 2014 Nov; 237(1):169-76.
    View in: PubMed
    Score: 0.033
  9. Coronary artery calcium testing: dos and don'ts. Cardiol Clin. 2012 Feb; 30(1):49-55.
    View in: PubMed
    Score: 0.027
  10. The contribution of early nephropathy to cardiovascular risk. Cardiol Clin. 2010 Aug; 28(3):427-36.
    View in: PubMed
    Score: 0.025
  11. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010 Apr 28; 303(16):1610-6.
    View in: PubMed
    Score: 0.025
  12. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009 Dec; 207(2):440-4.
    View in: PubMed
    Score: 0.023
  13. Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. Am Heart J. 2025 Apr; 282:146-155.
    View in: PubMed
    Score: 0.017
  14. Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 Jun; 81(6):1467-1478.e1.
    View in: PubMed
    Score: 0.017
  15. The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease. Vasc Med. 2024 12; 29(6):640-652.
    View in: PubMed
    Score: 0.017
  16. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
    View in: PubMed
    Score: 0.017
  17. Differing associations of PM2.5 exposure with systolic and diastolic blood pressures across exposure durations in a predominantly non-Hispanic Black cohort. Sci Rep. 2024 08 31; 14(1):20256.
    View in: PubMed
    Score: 0.017
  18. Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024 Dec 03; 150(23):1826-1836.
    View in: PubMed
    Score: 0.017
  19. Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 08 07; 14(8):e078197.
    View in: PubMed
    Score: 0.017
  20. Contextual Deprivation, Race and Ethnicity, and Income in Air Pollution and Cardiovascular Disease. JAMA Netw Open. 2024 08 01; 7(8):e2429137.
    View in: PubMed
    Score: 0.016
  21. Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2024 Jun 03; 31(8):1048-1054.
    View in: PubMed
    Score: 0.016
  22. Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
    View in: PubMed
    Score: 0.016
  23. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2023 11 01; 8(11):1061-1069.
    View in: PubMed
    Score: 0.016
  24. The Role of Health Insurance Type and Clinic Visit on Hypertension Status Among Multiethnic Chicago Residents. Am J Health Promot. 2024 03; 38(3):306-315.
    View in: PubMed
    Score: 0.016
  25. Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. JAMA Netw Open. 2023 09 05; 6(9):e2334590.
    View in: PubMed
    Score: 0.015
  26. Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE Study. J Am Heart Assoc. 2023 07 04; 12(13):e027899.
    View in: PubMed
    Score: 0.015
  27. Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE. Am Heart J. 2023 10; 264:31-39.
    View in: PubMed
    Score: 0.015
  28. Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. JAMA. 2022 10 04; 328(13):1315-1325.
    View in: PubMed
    Score: 0.015
  29. Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023 Feb; 77(2):506-514.
    View in: PubMed
    Score: 0.014
  30. NT-pro B-type natriuretic peptide, early menopause, and incident heart failure in postmenopausal women of the ARIC study. Menopause. 2022 01 14; 29(3):309-316.
    View in: PubMed
    Score: 0.014
  31. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
    View in: PubMed
    Score: 0.013
  32. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. JAMA. 2021 04 06; 325(13):1266-1276.
    View in: PubMed
    Score: 0.013
  33. High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study. Menopause. 2021 01 04; 28(3):284-291.
    View in: PubMed
    Score: 0.013
  34. Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease. Exp Gerontol. 2020 10 15; 140:111048.
    View in: PubMed
    Score: 0.012
  35. Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. J Vasc Surg. 2021 02; 73(2):608-625.
    View in: PubMed
    Score: 0.012
  36. Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 2020 08; 25(4):319-327.
    View in: PubMed
    Score: 0.012
  37. Meaningful change in 6-minute walk in people with peripheral artery disease. J Vasc Surg. 2021 01; 73(1):267-276.e1.
    View in: PubMed
    Score: 0.012
  38. Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy. J Am Heart Assoc. 2020 04 07; 9(7):e015197.
    View in: PubMed
    Score: 0.012
  39. Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial. Circ Res. 2020 02 28; 126(5):589-599.
    View in: PubMed
    Score: 0.012
  40. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease. J Vasc Surg. 2020 03; 71(3):988-1001.
    View in: PubMed
    Score: 0.012
  41. Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T With Cardiovascular Disease: The Cardiovascular Health Study. Am J Hypertens. 2019 09 24; 32(10):1013-1020.
    View in: PubMed
    Score: 0.012
  42. Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. J Am Heart Assoc. 2019 01 22; 8(2):e011001.
    View in: PubMed
    Score: 0.011
  43. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018 10 23; 138(17):e595-e616.
    View in: PubMed
    Score: 0.011
  44. Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance. Vasc Med. 2018 08; 23(4):340-348.
    View in: PubMed
    Score: 0.011
  45. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676.
    View in: PubMed
    Score: 0.011
  46. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. JAMA. 2017 12 05; 318(21):2089-2098.
    View in: PubMed
    Score: 0.010
  47. Femoral artery plaque characteristics, lower extremity collaterals, and mobility loss in peripheral artery disease. Vasc Med. 2017 12; 22(6):473-481.
    View in: PubMed
    Score: 0.010
  48. Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial. JAMA Cardiol. 2017 08 01; 2(8):902-907.
    View in: PubMed
    Score: 0.010
  49. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
    View in: PubMed
    Score: 0.010
  50. Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017 09; 66(3):826-834.
    View in: PubMed
    Score: 0.010
  51. Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events. JACC Cardiovasc Imaging. 2017 09; 10(9):1003-1012.
    View in: PubMed
    Score: 0.010
  52. European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry. Circulation. 2016 Jul 19; 134(3):201-11.
    View in: PubMed
    Score: 0.009
  53. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016 Jan 19; 67(2):139-147.
    View in: PubMed
    Score: 0.009
  54. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation. 2015 Sep 08; 132(10):916-22.
    View in: PubMed
    Score: 0.009
  55. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012 Aug 22; 308(8):788-95.
    View in: PubMed
    Score: 0.007
  56. Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials. 2012 Apr; 9(2):232-46.
    View in: PubMed
    Score: 0.007
  57. Use of carotid intima-media thickness to identify patients with ischemic stroke and transient ischemic attack with low yield of cardiovascular sources of embolus on transesophageal echocardiography. Stroke. 2008 Nov; 39(11):2969-74.
    View in: PubMed
    Score: 0.005
  58. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest. 2007 Apr; 131(4):964-71.
    View in: PubMed
    Score: 0.005
  59. Developing a conceptual framework for understanding illness and attitudes in older, urban African Americans with diabetes. Diabetes Educ. 2000 May-Jun; 26(3):439-49.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.